Combination of Leukocyte Cell Surface Biomarkers Measured by Cytometry, to Differentiate Bacterial From Viral Infections in Emergency Department: a Multicentric Cohort for the Validation of Diagnostic Performances

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

August 14, 2025

Study Completion Date

August 14, 2025

Conditions
Bacterial and Viral Infections
Interventions
DIAGNOSTIC_TEST

2 additional whole blood samples of 6mL each will be taken

"As part of the initial blood work-up, 2 additional samples of 6mL each of whole blood will be taken, to which 1mL of Cytodelics® Stabiliser will be added. The tubes will be mixed by inverting 10 to 15 times, incubated at +20°C for 10 minutes, then transported within 1 to 2 hours at 4°C by courier to the CRB at Pitié-Salpêtrière for aliquoting and freezing at -80°C . The expression level of cell surface markers will then be measured in series on an Aurora spectral cytometer, after frozen samples (1 to 2 aliquots) have been sent from the CRB-PSL to CIMI (INSERM U1135) at -80°C approximately once a month.~Any remaining samples sent to CIMI will be destroyed once the analyses have been completed."

Trial Locations (3)

75010

NOT_YET_RECRUITING

Service des urgences, Lariboisière, Paris

75012

NOT_YET_RECRUITING

Service des urgences, Saint-Antoine, Paris

75013

RECRUITING

Service des urgences, Pitié Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER